Markel Corporation MKL · NYSE
$1,856.75 +0.36% (+$6.62)
Summary
80 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Revenue grew by 12% a year over the last 3 years.
What to watch
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 10.1 USD for 1 USD of yearly profit. Over the last five years it was 9.4 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 12% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 38 USD
- Sales and administration 45 USD
- Taxes and other 3.9 USD
- Net profit 13 USD
Net profit, industry median (Insurance - Property & Casualty) 10 USD
Out of every 100 USD of revenue, 13 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 12
- Sell 3
Today's price within the analysts' price targets
The average target of $1,950 is 5.0% above today's price. 0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
- Insurance 45%
- Markel Ventures Operations 31%
- Investing Member 17%
- Reinsurance 6.3%
By region
The company reports no revenue by region.
Insurance brings in 45% of revenue. Markel Ventures Operations grew fastest, by 3.7% a year.
Segments in detail